Dr John Conibear

Dr John Conibear graduated from the University Hospital of Wales in 2001 and completed his post-graduate general medical training in The Barts and The London Training rotation in 2006. Before gaining his substantive post as a consultant clinical oncologist in St. Bartholomew’s Hospital in 2014, he completed a 2-year fellowship with the NCRI Radiotherapy Trials Quality Assurance Group in Mount Vernon Hospital. During his fellowship he conducted research into techniques to improve clinician target outlining during radiotherapy planning and was subsequently awarded a MD(Res) from UCL in 2018. Dr Conibear is currently the Deputy Medical Director of Barts Cancer Centre, and Deputy Director of Barts Cancer Centre. He is also the lead for chemotherapy and clinical director for thoracic oncology in St. Bartholomew’s Hospital. Dr Conibear is the oncology clinical lead for the RCP National Lung Cancer Audit (NLCA).

Dr Conibear specialises in all the non-surgical treatments for both lung and breast cancers. He has expertise in chemotherapy, biological therapies, immunotherapy, and state of the art radiotherapy techniques. Dr Conibear is also trained in using state of the art radiotherapy technologies and techniques including the ViewRay MRIdian MRI-guided linac, Accuray Cyberknife, Leksell Icon Gamma Knife and Proton Therapy. These technologies are used to deliver stereotactic ablative body or brain radiotherapy (SABR / SRS).